Publications by authors named "Don Yin"

Claim this Profile
O
Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.
György Jermendy, , Diana Erdesz, Laszlo Nagy, Don Yin

Health Qual Life Outcomes· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study.
Kenneth K C Lee, Vivian W Y Lee, Wai Kwong Chan, Benjamin S C Lee, Agnes C Y Chong, Don Yin

Value Health· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of new Joint British Societies' (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice.
Srinivasan Rajagopalan, Evo Alemao, Liz Finch, Don Yin

Curr Med Res Opin· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.
Kheng-Thye Ho, Khong-Whee Chin, Kheng-Siang Ng, Evo Alemao, Srinivasan Rajagopalan, Don Yin

Am J Cardiovasc Drugs· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study.
Evo Alemao, Don Yin, Harri Sintonen, Veikko Salomaa, Pekka Jousilahti

Am J Cardiovasc Drugs· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid management and cholesterol goal attainment in Norway.
Leiv Ose, Finn E Skjeldestad, Inger J Bakken, Andrée Levorsen, Evo A Alemao, Don D Yin

Am J Cardiovasc Drugs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.
Miriam C J M Sturkenboom, Wim G Goettsch, Gino Picelli, Bas in 't Veld, Don D Yin

Br J Clin Pharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
Eric Van Ganse, Laurent Laforest, Evo Alemao, Glenn Davies, Stephen Gutkin, Don Yin

Curr Med Res Opin· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How appropriate is asthma therapy in general practice?
Laurent Laforest, Yves Pacheco, Jean Bousquet, Vasilisa Sazonov Kocevar, Don Yin

Fundam Clin Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of care for patients treated with lipid-lowering drugs.
Asa Carlsson, Fredrik Borgström, Jan Stålhammar, Evo Alemao, Don Yin

Pharmacoeconomics· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.
John R Cook, Don Yin, Evo Alemao, Michael Drummond

Pharmacoeconomics· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.
John R Cook, Don Yin, Evo Alemao, Glenn Davies, Karl J Krobot

Pharmacoeconomics· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis